Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

White Matter Abnormalities and Cognitive Decline

Neurology; ePub 2018 Mar 23; Lindemer, et al

White matter signal abnormalities (WMSA) hold additional predictive power regarding cognitive progression in older individuals and are most effective as biomarkers in individuals who are cognitively impaired but do not fit the expected cerebrospinal fluid (CSF) biomarker profile of Alzheimer disease (AD), a recent study found. 236 individuals from the Alzheimer's Disease Neuroimaging Initiative database with clinical diagnoses of cognitively normal older adult (older controls [OCs]), mild cognitive impairment, and AD were studied. Researchers found:

  • CSF biomarkers alone classified individuals with AD vs OCs with 82% accuracy, and the addition of WMSA did not enhance this.
  • Both CSF biomarkers, as well as WMSA volume, significantly contributed to predicting cognitive decline in executive and memory domains when assessed across all individuals.
  • In individuals with pathologic levels of both CSF biomarkers, WMSA only significantly contributed to models of future executive function decline.
  • In individuals with subpathologic CSF biomarker levels (levels similar to those in OC individuals), WMSA significantly contributed to prediction of memory decline and were the sole significant predictor of executive function decline.

Citation:

Lindemer ER, Greve DN, Fischl B, Salat DH, Gomez-Isla T. White matter abnormalities and cognition in patients with conflicting diagnoses and CSF profiles. [Published online ahead of print March 23, 2018]. Neurology. doi:10.1212/WNL.0000000000005353.

This Week's Must Reads

Pediatric Onset MS Linked with Reduced Parental QOL, Mult Scler; ePub 2018 Aug 30; O’Mahony, et al

Depressive Symptoms Negatively Impact on MS, J Neuropsychiatry Clin Neurosci; ePub 2018 Sep 6; Gill, et al

Evaluation of the MULES Picture Naming Test, J Neurol Sci; ePub 2018 Aug 23; Seay, Akhand, et al

Postrelapse Rehabilitation Use in MS Examined , Int J MS Care; ePub 2018 Sep 5; Asano, Eitzen, et al

Thalamic White Matter in Patients with MS, Hum Brain Mapp; 2018 Oct; Bergsland, et al

Must Reads in Alzheimer's & Cognition

Prevalence and Incidence of AD Dementia Examined, Alzheimers Dement; ePub 2018 Sep 6; Rajan, et al

Link Found Between Ophthalmic Conditions, AD Risk, Alzheimers Dement; ePub 2018 Aug 8; Lee, et al

Spatial Heterogeneity of White Matter Lesions , Neurology; ePub 2018 Aug 3; Habes, et al

Gender and Cognition in Overweight Adults with T2D, Alzheimers Dement; ePub 2018 Jul 4; Espeland, et al

MCI, Dementia Linked with Vascular Risk Factors, Alzheimers Dement; ePub 2018 May 12; Knopman, et al